How has been the historical performance of Valiant Organics?
Valiant Organics has faced significant fluctuations in financial performance, with net sales declining from 1,051.80 Cr in March 2023 to 718.76 Cr in March 2025, while profitability metrics have also decreased, resulting in a negative profit after tax of -2.67 Cr in March 2025. Despite a slight recovery in operating profit, the overall financial environment remains challenging.
Answer:The historical performance of Valiant Organics has shown significant fluctuations over the years, particularly in net sales and profitability.Breakdown:
Valiant Organics reported net sales of 718.76 Cr in March 2025, a slight decline from 723.06 Cr in March 2024 and a notable decrease from 1,051.80 Cr in March 2023. The total operating income mirrored this trend, falling to 718.76 Cr in March 2025 from 723.06 Cr in the previous year and down from 1,051.80 Cr in March 2023. The raw material costs also decreased to 440.07 Cr in March 2025 from 483.40 Cr in March 2024, contributing to a total expenditure of 665.09 Cr in March 2025, which was lower than 684.81 Cr in March 2024. Operating profit (PBDIT) rose to 62.31 Cr in March 2025 from 47.55 Cr in March 2024, but this was significantly lower than the 172.26 Cr reported in March 2023. The profit before tax showed a recovery to 2.91 Cr in March 2025 from a loss of 7.13 Cr in March 2024, yet it was down from 137.18 Cr in March 2023. The profit after tax remained negative at -2.67 Cr in March 2025, although it improved from -6.84 Cr in March 2024. The consolidated net profit also reflected this trend, standing at -3.74 Cr in March 2025 compared to -8.39 Cr in March 2024 and a profit of 88.12 Cr in March 2023. Total assets decreased to 1,182.93 Cr in March 2025 from 1,247.96 Cr in March 2024, while total liabilities also fell to 1,182.93 Cr from 1,247.96 Cr. Cash flow from operating activities was 56.00 Cr in March 2025, down from 84.00 Cr in March 2024, indicating a decline in cash generation capabilities. Overall, Valiant Organics has experienced a challenging financial environment with fluctuating sales and profitability metrics over the past few years.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
